|Bid||17.10 x 800|
|Ask||17.35 x 800|
|Day's range||16.82 - 17.60|
|52-week range||16.81 - 95.98|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||06 May 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||41.19|
Intercept (ICPT) posts a narrower loss for the first quarter. Also, sales surpass expectations. However, Ocaliva's safety label remains a concern.
ICPT earnings call for the period ending March 31, 2021.
Intercept (ICPT) delivered earnings and revenue surprises of 20.26% and 1.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?